Leslie Wilson spends much of his time researching Microtubule, Tubulin, Cell biology, Mitosis and Biophysics. His Microtubule research incorporates themes from Polymerization, Vinblastine, Biochemistry, Binding site and Video microscopy. The various areas that Leslie Wilson examines in his Biochemistry study include Dimer, Stereochemistry and Colchicine.
The study incorporates disciplines such as Eribulin, Paclitaxel and GTP' in addition to Tubulin. His Cell biology research is multidisciplinary, incorporating perspectives in Tau protein, Molecular mechanism, Microtubule nucleation, Cytoskeleton and Programmed cell death. His Mitosis research is multidisciplinary, relying on both Spindle apparatus, Anaphase and Cell growth.
The scientist’s investigation covers issues in Microtubule, Tubulin, Biophysics, Cell biology and Biochemistry. Pharmacology is closely connected to Paclitaxel in his research, which is encompassed under the umbrella topic of Microtubule. His study in Tubulin is interdisciplinary in nature, drawing from both Vinblastine, In vitro, GTP' and Colchicine.
The concepts of his Biophysics study are interwoven with issues in Video microscopy and Binding site. Specifically, his work in Cell biology is concerned with the study of Mitosis. His studies in Mitosis integrate themes in fields like Spindle apparatus, Cell cycle, Anaphase and Cell growth.
His main research concerns Microtubule, Biophysics, Internal medicine, Tubulin and Randomized controlled trial. Microtubule is the subject of his research, which falls under Cell biology. His studies deal with areas such as Transmission electron microscopy, Tau protein and Liposome as well as Biophysics.
His Internal medicine research includes themes of Surgery and Oncology. Leslie Wilson combines subjects such as Cancer research, In vitro and Paclitaxel with his study of Tubulin. His Randomized controlled trial research incorporates elements of Anorexia nervosa, Intervention, Decision support system, Physical therapy and Prostate cancer.
Leslie Wilson mainly investigates Pharmacology, Tubulin, Microtubule, Randomized controlled trial and Gerontology. He focuses mostly in the field of Pharmacology, narrowing it down to matters related to Paclitaxel and, in some cases, Eribulin, Sciatic nerve, Docetaxel and In vitro. His research in Tubulin intersects with topics in Cell, Cancer research, Neurodegeneration, Tauopathy and GTP'.
His research on Microtubule concerns the broader Cell biology. His Randomized controlled trial study combines topics in areas such as Intervention, Young adult, Pediatrics and Confidence interval. His Gerontology study integrates concerns from other disciplines, such as Dementia, Disease, Health care and MEDLINE.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
Mary Ann Jordan;Robert J. Toso;Doug Thrower;Leslie Wilson.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Mitotic Block Induced in HeLa Cells by Low Concentrations of Paclitaxel (Taxol) Results in Abnormal Mitotic Exit and Apoptotic Cell Death
Jordan Ma;Wendell K;Gardiner S;Derry Wb.
Cancer Research (1996)
Microtubules and actin filaments: dynamic targets for cancer chemotherapy
Mary Ann Jordan;Leslie Wilson.
Current Opinion in Cell Biology (1998)
Opposite end assembly and disassembly of microtubules at steady state in vitro
Robert L. Margolis;Leslie Wilson.
Mechanism of Inhibition of Cell Proliferation by Vinca Alkaloids
Mary Ann Jordan;Douglas Thrower;Leslie Wilson.
Cancer Research (1991)
Annual direct cost of urinary incontinence.
Leslie Wilson;Jeanette S Brown;Grace P Shin;Kim-Oanh Luc.
Obstetrics & Gynecology (2001)
Properties of colchicine binding protein from chick embryo brain. Interactions with vinca alkaloids and podophyllotoxin.
The Direct Cost and Incidence of Systemic Fungal Infections
Leslie S. Wilson;Carolina M. Reyes;Michelle Stolpman;Julie Speckman.
Value in Health (2002)
The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth
Mary Ann Jordan;Kathryn Kamath;Tapas Manna;Tatiana Okouneva.
Molecular Cancer Therapeutics (2005)
Nucleoside transport in mammalian cells. Inhibition by colchicine.
Steven B. Mizel;Leslie Wilson.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: